1[1] Kevin Ho,Cdin G,Jonathem N W,et al．Cloning and expression of an inwardly recitifing ATP-regulated potassium channel[J] ．Nature,1993,362:31-38
2[2] Noma A．ATP-regulated K+ channels in cardiac muscle[J] ．Nature,1983，305:147-148
3[3] Nichols CG,Lederer W J．Adenosine triphosphate-sensitive potassium channels in the cardiovascular system[J]．Am J Physiol,1991,261:H1675-1686
4[4] Robertson DW,Steinberg MI．Potassium channel modulators:scientific applications and therapeutic promise[J] ．J Med Chem,1990,3:1538-1541
5[5] Grover GJ,Dzwonczky S,Parham CS,et al．The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated rat hearts and anesthetized dogs[J] ．Cardiovasc Drugs Ther,1990,15:465-474
6[6] Auchampach JA,Gross GJ．Reduction in myocardial infarct size by the new potassium channel opener bimakalim[J]．J Cardiovasc Pharmacol,1994,23:554-561[ZK)〗
7[7] Cole WC,Mc Pherson CV D,Sontag D．ATP-regulated potassium channels protect the myocardium against ischemia/reperfusion damage[J] ．Circ Res1991,69．571-581
8[8] Bolli R．Mechanism of myocardial“stunning”．Circulation,1990,82:723-738
9[9] Auchampach JA,lcilio BS,Caverol,et al．Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels[J]．J Cardiovasc Pharmacol,1992,20:765-771
10[10] Auchampach JA,Maruyama M,Caverol,et al．Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning[J] ．Circulation,1993,86:311-319
